SCHEMBL12295346

SCHEMBL12295346

Nc1ncc2c(ccn2Cc2ccccc2)c1-c1cc2ccccc2o1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 2/20 0.42
CYP11B1 P15538 1/20 0.41
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 2/20 0.41
GAA P10253 1/20 0.41
ALOX12 P18054 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KLKB1 P03952 1/20 0.40
KLK1 P06870 1/20 0.40
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ADORA2A P29274 1/20 0.38
GRM4 Q14833 1/20 0.38
MKNK1 Q9BUB5 1/20 0.37
IDO1 P14902 1/20 0.37
HTR6 P50406 1/20 0.37
ADK P55263 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12294349 0.78 KDM1A (0.39) MKNK1
Hydrochloric Acid SCHEMBL14321309 0.77 KDM1A (0.39) MKNK1
SCHEMBL2369372 0.74 FGFR1 (0.38) ALDH1A1HPGDSMN1; SMN2MKNK1ADK
SCHEMBL2369583 0.72 SLC2A1 (0.49) SLC2A1CYP11B1KLKB1KLK1KMT2A
SCHEMBL12294123 0.71 MMP13 (0.41) KDM4EHTR6
SCHEMBL14321882 0.71 MKNK1 (0.36) ALDH1A1HPGDSMN1; SMN2MKNK1NPC1
SCHEMBL14321740 0.70 KDM4E (0.48) CYP11B1KDM4EALDH1A1HPGDGAA
SCHEMBL12293746 0.69 ADRA2A (0.47) KDM4EALDH1A1HPGDHSD17B10ADORA2A
SCHEMBL17981498 0.68 ADORA2A (0.40) ALDH1A1ADORA2AHTR6ADKHTR1A
SCHEMBL17981147 0.68 ADORA2A (0.47) ALDH1A1ADORA2AMKNK1HTR6ADK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120329826-A1 SUBSTITUTED-5-AMINOPYRROLO/PYRAZOLOPYRIDINES OSI Pharmaceuticals,. LLC 2012-12-27 US disclosed
US-20120329826-A1 SUBSTITUTED-5-AMINOPYRROLO/PYRAZOLOPYRIDINES OSI Pharmaceuticals,. LLC 2012-12-27 US disclosed
US-20120329826-A1 SUBSTITUTED-5-AMINOPYRROLO/PYRAZOLOPYRIDINES OSI Pharmaceuticals,. LLC 2012-12-27 US disclosed
WO-2011109593-A1 SUBSTITUTED-5-AMINOPYRROLO/PYRAZOLOPYRIDINES OSI Pharmaceuticals, LLC (US) 2011-09-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120329826-A1 SUBSTITUTED-5-AMINOPYRROLO/PYRAZOLOPYRIDINES MET, KRAS, VHL SLC2A1 193/4885CYP11B1 77/4885KDM4E 2706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.